Related Experiment Video

Updated: Jun 12, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Results with cyclosporine monotherapy in long-term cardiac transplant recipients

F Sansone1, M Boffini, C Comoglio

  • 1Division of Cardiac Surgery, University of Turin, San Giovanni Battista Hospital, Turin, Italy. fabrisans@katamail.com

Transplantation Proceedings
|June 11, 2010
PubMed

Insights

Long-term heart transplant survivors showed similar outcomes on cyclosporine monotherapy versus double therapy. While triple therapy remains standard, this study suggests cyclosporine monotherapy may be a viable option for select patients.

Area of Science:

  • Cardiology
  • Immunosuppression
  • Transplantation

Background:

  • Triple therapy is the established standard for immunosuppression post-heart transplantation.
  • Limited data exists on the long-term efficacy and safety of cyclosporine monotherapy (CM).
  • This study investigates CM in heart transplant recipients with over 5 years of survival.

Purpose of the Study:

  • To evaluate the long-term outcomes of cyclosporine monotherapy (CM) in heart transplant recipients.
  • To compare the efficacy and safety of CM against double therapy (DT).
  • To assess the utility of CM in patients surviving beyond 5 years post-transplant.

Main Methods:

  • Retrospective analysis of 219 heart transplant patients (1990-1998).
  • 143 patients surviving >5 years were analyzed.
  • 41 patients on double therapy (cyclosporine + Azathioprine) were matched with 41 patients on cyclosporine monotherapy.

Main Results:

  • No significant difference in survival rates between CM and DT groups after a mean follow-up of 119.8 months.
  • Major adverse events, including heart failure, malignancy, dialysis, infections, and Cardiac Allograft Vasculopathy (CAV), were comparable.
  • Long-term outcomes were similar for patients on CM and DT.

Conclusions:

  • Triple therapy is recommended for heart transplant recipients due to its proven safety and efficacy.
  • The study suggests that cyclosporine monotherapy may be a useful alternative for select long-term heart transplant survivors.
  • Further research may explore the specific patient profiles that benefit most from CM.
Abstract

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...